Medical Countermeasure Monitoring and Assessment
This webpage is focused on the need to build and maintain a national capability to monitor and assess medical countermeasures (MCMs) after they are dispensed or administered in response to a chemical, biological, radiological, or nuclear threat or an emerging infectious disease. Links to “FDA Information about Past and Current MCM Monitoring and Assessment Projects,” including those relevant to COVID-19, are included.
Favorite:
Login to rate, favorite, and comments
on the article
Comments
0
Toggle Open/Close
You must Login to add a comment
- This item doesn't have any comments